Open Your Demat Account In Minutes
Open Free Demat Account
Financials
Quarterly Report 2024
Financials for quarter and nine months/ half-year / year that ended
Recent Investor Presentation
Annual General Meeting for FY 2023-24
Annual General Meeting for FY 2022-23
Annual General Meeting for FY 2020-21
Annual General Meeting for FY 2021-22
- Voting Results and Scrutinizer's Report 2023-24
- AGM Proceedings 2023-24
- Intimation of Record date for AGM 2023-24
- Intimation of Book Closure dates for AGM 2023-24
- Business Responsibility & Sustainability Report (BRSR) 2023-24
- Annual Report 2023-24
- Notice of AGM 2023-24
- Annual Return 2023-24
- Voting Results and Scrutinizer's Report 2022-23
- AGM Proceedings - 2022-23
- 16th Annual Report 2022 - 2023
- Annual Report 2022-23
- BRSR- Business Responsibility & Sustainability Report-2022-23
- Stock Exchange Intimation- AGM Notice & Annual Report
- Record date Intimation
- Book Closure Intimation
- Notice of AGM 2022-23
- Annual Return 2022-23
- Annual Report 2021-22
- Annual Return 2021-22
- Outcome of Board Meeting held on 08-10-2020
- Outcome of Board Meeting held on January 13 2021
- Book Closure Intimation
- Notice of AGM 2021-22
- Stock Exchange Intimation-AGM Notice 2021-22
- Financial Results for quarter & Year Ended March 2022
- Scrutinizer's Report
- Book Closure Intimation
- Voting Results-2020-21
- AGM proceedings-2020-21
- Annexure II-MGT-9
- Corrigendum to AGM Notice
- Stock Exchange Intimation-AGM Notice
- Annual Report 2020-21
- Notice of AGM 2020-21
- Annual Report 2014-15
- Annual Report 2015-16
- Annual Report 2017-18
- Notice of the AGM : 2017-18
- Attendance Slip 2017-18
- Proxy form 2017-18
- Financials of 5paisa P2P Limited 2017-18
- SEBI Regulation ESOP Disclosure 2017-18
- Stock exchange intimations outcome 2018-19
- Financials of 5paisa P2P Limited
- Financials of 5paisa Insurance Brokers Limited
- SEBI Regulation ESOP Disclosure
- Proxy form 2018-19
- Attendance Slip 2018-19
- Notice of the AGM : 2018-19
- Annual Report 2018-19
- Stock exchange intimations outcome 2019-20
- Stock exchange intimations outcome 2019-20
- Annual Report 2016-17
- Stock Exchange Intimation
- Annual Report 2019-20 (PDF)
- Notice of AGM 2019-20
- Stock Exchange Intimation - Prior Notice Intimation
- Stock Exchange Intimation - Intimation of AGM Notice
- SEBI Regulation ESOP Disclosure
- Annexure-II(MGT-9)
Reports On subsidiaries
5paisa Trading Ltd.
5paisa P2P Ltd.
5paisa Corporate
Services Ltd.
5paisa International
Securities (IFSC) Ltd.
No files in this Financial Year
- Annual return
- Important information, notices, reports
- Stock Exchange disclosures
- Shareholding & Ownership
- Shareholders / Investors helpdesk
- Secretarial Compliance Report
- Schedule of investors/ analysts meets
- Recordings/ transcripts of analysts meets
- Newspaper Advertisements
- Investor Presentation
- Grievance redressal information
- Audited Financial Statements of subsidiaries
- Financial information
- Familiarization of Independent Directors
- Details of business
- Credit Ratings
- Composition of the Board of Directors
- Composition of Committees of the Board
- Codes and Policies of the Company
- Authorized KMP under Policy for Determination of Materiality of Information / Events
- Terms and conditions of the appointment of Independent Directors
- Annual Report
Additional Resources
Mr. Ameya Agnihotri - Whole-time Director & Chief Technology Officer (CTO):
Mr. Ameya Agnihotri is a Bachelor of Computer Science and holds a master’s degree in computer applications. Mr. Ameya Agnihotri brings over 18 years of diverse experience in building scalable, low latency, resilient platforms, large scale data platforms in AdTech and MarTech space (SSP, DSP, CDP, DMP) as well as in OTA and logistics. Mr. Ameya Agnihotri’s previous experience includes working at Paytm, Zeotap, Airpush, Pubmatic and Symantec. Prior to joining 5paisa as a CTO from November 2023, he was VP - Technology at Paytm (Travel Vertical).
Mr. Gourav Munjal - Whole-Time Director & Chief Financial Officer (CFO):
Mr. Gourav Munjal has a bachelor’s degree in commerce from Kurukshetra University and is a qualified Chartered Accountant, Company Secretary and a diploma holder in IFRS from the Association of Chartered Certified Accountants (ACCA). He has more than 13 years of experience in the field of Finance, Accounts, Treasury, MIS, Cost Control and Process improvements. Before joining the Company, he was associated with the IIFL Group and has handled same functions.
Dr. Archana Niranjan Hingorani – Chairperson & Independent Director:
Dr. Archana Hingorani holds an M.B.A. and Ph.D. in Finance from the University of Pittsburgh, United States. She has over three decades of experience in the asset management business, teaching and research. She has been associated with the IL&FS Group until 2017 in various capacities, including CEO of IL&FS Investment Managers Limited. Beyond garnering rich experience in fundraising, investing, nurturing investments through four different economic cycles and carving exit paths, among others, she has mentored and nurtured smaller start-ups in technology, education, financial inclusion, with a special focus on enterprises run by women. She has been named as the most influential woman in India by various publications, including Business Today in 2011, 2012 and 2013; Asian Investor in 2014 and Fortune India in 2014, 2015 and 2016.
Ms. Nirali Sanghi - Independent Director:
Ms. Nirali Sanghi founded India Parenting Private Limited in 1999 and serves as its Chief Executive Officer and President. Prior to that, she served at Erstwhile Baring Brothers (New York), Citibank (New York and Mumbai) and The Boston Consulting Group (Mumbai). Ms. Sanghi has a bachelor’s degree in Economics and Computer Science from Barnard College, Columbia University, New York, USA and M.B.A. in Finance and Marketing from Columbia Business School (New York, USA).
Mr. Milin Mehta - Independent Director:
Mr. Milin Mehta is a Law Graduate and Chartered Accountant by profession. He has over three decades of experience in the areas ranging from accounting, tax, valuations, strategies, governance and law. He cherishes arguing in complex tax litigations and has to his credit several reported decisions, some of which are pathbreaking. He was invited by the Finance Ministry, Government of India, through CBDT to be member of the committee appointed for formulation of ICDS as well as MAT Computation under Ind-AS scenario. Mr. Milin Mehta actively participates in the activities of the Institute of Chartered Accountants of India. Being a prolific speaker he has delivered talks in seminars and conferences held at national level which also facilitated him to develop an excellent network amongst the professionals. Further, he also serves as an Independent Director across various listed and unlisted companies and also chairs their audit committees.
Mr. Ravindra Garikipati - Independent Director:
Mr. Ravindra Garikipati is an entrepreneur and technologist with over three decades of experience, largely in technology and executive leadership roles. He is a Board member and advisor to many late-stage start ups and an active angel investor in deep tech, fintech and consumer tech start-ups. He has recently co-founded a fintech start-up Davinta Finserv, which focuses on financial inclusion for the bottom of the pyramid. Prior to that, as a CTO at Flipkart, he defined and executed the technology vision and roadmap to transform commerce. Before his stint at Flipkart, he was the President and Chief Technology Officer at [24]7.ai, a Sequoia funded company where he led global product and technology groups to build one of the largest omni-channel client acquisition and engagement platforms. He has also held various senior engineering management positions at Oracle and Covansys, where he gained extensive experience in building scalable enterprise application architectures and services.
Committee Nomination and
Remuneration Stakeholder
Relationship Risk
Management Corporate Social
Responsibility Finance
Committee Environmental, Social and
Governance (ESG) Committee Independent Directors (ID)
Committee Information Technology (IT)
Committee Cyber Security
Committee
Name of Member | Designation |
---|---|
Mr. Milin Mehta | Chairman |
Ms. Nirali Sanghi | Member |
Dr. Archana Niranjan Hingorani | Member |
Mr. Ravindra Garikipati | Member |
The scope of the Audit Committee includes the references made under Regulation 18 read with Part C of Schedule II of Listing Regulations as well as section 177 and other applicable provisions of the Act, besides the other terms that may be referred by the Board of Directors.
The Committee is governed by a Charter, which is in line with the regulatory requirements mandated by the Act and the Listing Regulations. The terms of reference of the Audit Committee, inter alia, includes the following:
1. Oversight of your Company’s financial reporting process and the disclosure of its financial information to ensure that the financial statement is correct, sufficient, and credible.
2. Recommendation for appointment, re-appointment, and replacement, remuneration and terms of appointment of auditors of your Company.
3. Approval of payment to statutory auditors for any other services rendered by the statutory auditors.
4. Reviewing, with the management, the annual financial statements and auditor’s report thereon before submission to the board for approval, with particular reference to:
a. Matters required to be included in the Director’s responsibility statement to be included in the Board’s report in terms of clause (c) of sub-section 3 of section 134 of the Act.
b. Changes, if any, in accounting policies and practices and reasons for the same.
c. Major accounting entries involving estimates based on the exercise of judgment by management.
d. Significant adjustments made in the financial statements arising out of audit findings.
e. Compliance with listing and other legal requirements relating to financial statements.
f. Disclosure of any related party transactions.
g. Qualifications/modified opinions in the draft audit report.
5. Reviewing the quarterly financial statements with the management before submission to the Board for approval.
6. Reviewing, with the management, the statement of uses/application of funds raised through an issue (public issue, rights issue, preferential issue, etc.), the statement of funds utilized for purposes other than those stated in the offer document/prospectus/notice, and the report submitted by the monitoring agency monitoring the utilization of proceeds of a public or rights issue and making appropriate recommendations to the Board to take up steps in this matter.
7. Review and monitor the auditor’s independence and performance and effectiveness of the audit process.
8. Approval or any subsequent modification of transactions of your Company with related parties.
9. Scrutiny of inter-corporate loans and investments.
10. Valuation of undertakings or assets of your Company, wherever it is necessary.
11. Evaluation of internal financial controls and risk management systems.
12. Monitoring the end use of funds raised through public offers and related matters, if any.
13. Reviewing, with the management, the performance of statutory and internal auditors, adequacy of the internal control systems.
14. Reviewing the adequacy of the internal audit function, if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure coverage, and frequency of internal audit.
15. Discussion with internal auditors of any significant findings and follow-up thereon.
16. Reviewing the findings of any internal investigations by the internal auditors into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to the Board.
17. Discussion with statutory auditors before the commencement of the audit, about the nature and scope of the audit as well as post-audit discussion to ascertain any area of concern.
18. The Audit Committee may call for the comments of the auditors about internal control systems, the scope of audit, including the observations of the auditors and review of financial statements before their submission to the Board, and may also discuss any related issues with the internal and statutory auditors and the management of your Company.
19. To look into the reasons for substantial defaults in the payment to the depositors, debenture holders, shareholders (in case of non-payment of declared dividends), and creditors.
20. To establish and review the functioning of the whistleblower mechanism.
21. Approval of appointment of the Chief Financial Officer after assessing the qualifications, experience, and background, etc. of the candidate.
22. Related Party Transactions:
a. All related party transactions shall require prior approval of the Audit Committee.
b. The Audit Committee may grant omnibus approval for related party transactions proposed to be entered into by your Company subject to the following conditions, namely:
i. The criteria for granting the omnibus approval shall be specified, which shall be in line with your Company’s policy on related party transactions and such approval shall be based on the factors, namely repetitiveness of the transactions (in the past or in the future) and the justification for the need for omnibus approval.
ii. The Audit Committee shall satisfy itself on the need for omnibus approval for transactions of repetitive nature and that such approval is in the interest of your Company.
iii. Such omnibus approval shall not be made for transactions in respect of selling or disposing of the undertaking of your Company.
c. The omnibus approval shall specify:
i. The name(s) of the related party, nature of transaction, period of transaction, maximum value of transactions that shall be entered into, and the value of transactions, in aggregate, which can be allowed under the omnibus route in a year.
ii. The extent and manner of disclosures to be made to the Audit Committee at the time of seeking omnibus approval.
iii. The indicative base price or current contracted price and the formula for variation in the price, if any.
iv. Such other conditions as the Audit Committee may deem fit.
Provided that where the need for related party transactions cannot be foreseen and aforesaid details are not available, the committee may grant omnibus approval for such transactions subject to their value not exceeding ₹ 1 crore per transaction.
d. The Audit Committee shall review, at least on a quarterly basis, the details of related party transactions entered into by your Company pursuant to each of the omnibus approvals given.
e. Such omnibus approvals shall be valid for a period not exceeding one (1) financial year and shall require fresh approvals after the expiry of such financial year.
f. However, such prior and omnibus approval shall not be required in case of the transactions entered into between the company and its wholly-owned subsidiary/subsidiaries whose accounts are consolidated with your Company and placed before the shareholders at the general meeting for approval.
23. Review of:
a. Management discussion and analysis of financial condition and results of operations.
b. Statement of significant related party transactions (as defined by the audit committee), submitted by management.
c. Management letters/letters of internal control weaknesses issued by the statutory auditors.
d. Internal audit reports relating to internal control weaknesses.
e. The appointment, removal, and terms of remuneration of the chief internal auditor shall be subject to review by the audit committee.
f. Statement of deviations including:
i. Quarterly statement of deviation(s) including report of monitoring agency, if applicable, submitted to stock exchange(s) in terms of Regulation 32(1) of the SEBI Listing Regulations.
ii. Annual statement of funds utilized for purposes other than those stated in the offer document/prospectus/notice in terms of Regulation 32(7) of the SEBI Listing Regulations.
g. The utilization of loans and/or advances from/investment by the holding company in the subsidiary exceeding ₹ 100 crore or 10% of asset size of the subsidiary, whichever is lower, including existing loans/advances/investments and all other terms of reference of the committee shall remain unchanged.
h. The Audit Committee shall have the authority to investigate any matter in relation to the items specified above and for this purpose shall have the power to obtain professional advice from external sources and have full access to information contained in the records of your Company.
i. Carrying out any other terms of reference as may be decided by the Board or specified/provided under the Act or the Listing Regulations or by any other regulatory authority.
Name of Member | Designation |
---|---|
Ms. Nirali Sanghi | Chairperson |
Dr. Archana Niranjan Hingorani | Member |
Mr. Ravindra Garikipati | Member |
The scope of the NRC includes the references made under Regulation 19 of Listing Regulations, as amended, read with section 178 and other applicable provisions of the Act, besides the other terms that may be referred by the Board of Directors. The Brief terms of reference of the Nomination and Remuneration Committee, inter alia, includes the following:
1. Succession planning of the Board of Directors and Senior Management Employees.
2. Identifying and selection of candidates for appointment as Directors/Independent Directors, based on certain laid down criteria.
3. Identifying potential individuals for appointment as Key Managerial Personnel (KMP) and to other Senior Management positions.
4. Formulate and review from time to time the policy for selection and appointment of Directors, Key Managerial Personnel, and Senior Management employees and their remuneration.
5. Review the performance of the Board of Directors and Senior Management Employees based on certain criteria, as approved by the Board. In reviewing the overall remuneration of the Board of Directors and Senior Management, the Committee ensures that the remuneration is reasonable and sufficient to attract, retain, and motivate the best managerial talent. It also ensures that the relationship of remuneration to performance is clear, that the performance meets the appropriate performance benchmarks, and that the remuneration involves a balance between fixed and incentive pay, reflecting the short-term and long-term objectives of your Company.
NRC also administers our Company’s Stock Option plans. The stock options granted by the Committee are disclosed in detail in the Directors’ Report.
Name of Member | Designation |
---|---|
Ms. Nirali Sanghi | Chairperson |
Dr. Archana Hingorani | Member |
Mr. Ameya Agnihotri | Member |
The Committee is governed by a Charter, which is in line with the regulatory requirements mandated by the Act and the Listing Regulations. The terms of reference of the Stakeholders Relationship Committee, inter alia, includes the following:
1. To consider and resolve stakeholders and investors' grievances.
2. It shall consider and resolve the grievances of the security holders of your Company, including complaints related to transfer of shares, non-receipt of the annual report, and non-receipt of declared dividends.
3. To approve the allotment of shares, debentures, and other securities as per the authority conferred to the Stakeholders Relationship Committee by the Board of Directors, from time to time.
4. To approve/authorize the officers of your Company to approve requests for transfer, transposition, deletion, consolidation, sub-division, change of name/address, etc., in respect of shares, debentures, and securities received by your Company.
5. To review or address the complaints received by your Company from investors, SEBI, the Stock Exchanges, Ministry of Corporate Affairs, etc., and the action taken for redressal of the same and to suggest a resolution of long-pending complaints.
6. To approve and ratify the action taken by the authorized officers of your Company in compliance with investors for issues of duplicate/replacement/consolidation/sub-division and other purposes for the shares, debentures, and securities of your Company.
7. To monitor and expedite the status and process of dematerialization and rematerialization of shares, debentures, and securities of your Company.
8. To give directions for monitoring the stock of blank stationery and for printing of stationery required by the secretarial department of your Company, from time to time, for issuance of share certificates, debenture certificates, allotment letters, warrants, pay orders, cheques, and other related stationery.
9. To review the status of unpaid dividends, interest, and undelivered share certificates and the measures taken by your Company to resolve or reduce them.
10. To ensure compliance with the transfer of unpaid dividends and shares to IEPF on or before the due date.
11. To monitor the progress of release of unpaid dividends and the process of dissemination of these records in accordance with the prescribed guidelines, rules, and regulations.
12. To review the results of any investigation or audit conducted by any statutory authority.
13. Review the effectiveness of the system for monitoring compliance with laws and regulations.
14. Review the mechanism for handling investor complaints and the status of any pending complaints which remain unresolved or unattended.
15. Any significant or important matters affecting the interest of your Company.
Name of Member | Designation |
---|---|
Dr. Archana Hingorani | Chairperson |
Mr. Milin Mehta | Member |
Mr. Lalit Babu Lathe | Member |
Mr. Gourav Munjal | Member |
Mr. Ameya Agnihotri | Member |
Mr. Yogesh Maroli | Member |
The Committee is governed by a Charter, which is in line with the regulatory requirements mandated by the Listing Regulations. The terms of reference of the Risk Management Committee, inter alia, includes the following:
1. Reviewing risks, including cyber security, and evaluating the treatment, including initiating mitigation actions;
2. To monitor and review the overall risk management plan of your Company, including liquidity risk;
3. To ensure there is an embedded, robust process in place throughout your Company to identify, assess, mitigate, and report business risks with clear lines of ownership;
4. Laying down the risk tolerance limits and monitoring risk exposures at periodic intervals;
5. To drive and coordinate the risk management process covering all areas of risk (including operational, strategic, financial, commercial, regulatory, reputational, etc.);
6. To ensure that the business risk strategy and management processes comply with applicable regulatory requirements and corporate governance principles;
7. To ensure that the business risk management principles and processes are widely understood across your Company through adequate induction, training, and awareness programs;
8. To periodically monitor and review your Company’s key business risks and risk mitigation plans, and advise the Board of business risks which could materially impact your Company’s delivery of its business plans, strategy, and reputation, if left untreated;
9. To monitor external developments in the business environment which may have an adverse impact on your Company’s risk profile and make recommendations, as appropriate;
10. To sponsor specialist reviews of key risk areas as appropriate;
11. To report to the Board on key risks, risk management performance, and the effectiveness of internal controls on a periodical basis;
12. To constitute an operating risk management committee and delegate such powers to it as may be deemed necessary;
13. To formulate a detailed ERM policy, this shall include:
a. A framework for identification of internal and external risks specifically faced by the organization, including financial, operational, sectoral, sustainability (particularly ESG-related risks), information, cyber security risks or any other risk as may be determined by the Committee;
b. Measures for risk mitigation, including systems and processes for internal control of identified risks;
c. Business continuity Plan.
14. To ensure that appropriate methodology, processes, and systems are in place to monitor and evaluate risks associated with the business of the Company;
15. To monitor and oversee the implementation of the risk management policy, including evaluating the adequacy of risk management systems;
16. To periodically review the risk management policy, at least once in two years, including by considering the changing industry dynamics and evolving complexity;
17. To keep the board of directors informed about the nature and content of its discussions, recommendations, and actions to be taken;
18. To review the appointment, removal, and terms of remuneration of the Chief Risk Officer/Designated Risk Officer;
19. Any other matter as may be mandated/referred by the Authority/Board.
Name of Member | Designation |
---|---|
Dr. Archana Hingorani | Chairperson |
Ms. Nirali Sanghi | Member |
Mr. Gourav Munjal | Member |
Mr. Ameya Agnihotri | Member |
The terms of reference of the Corporate Social Responsibility (CSR) Committee, inter alia, includes the following:
1. Formulating and recommending to the Board, the CSR Policy which shall indicate the activities to be undertaken by your Company as specified in Schedule VII to the Act. The CSR policy of your Company may be accessed on your company’s corporate website at https://www.5paisa.com/investor-relations.
2. Making recommendations on the amount of the expenditure to be incurred on CSR activities;
3. Instituting a transparent monitoring mechanism for implementation of the CSR activities to be undertaken by your Company;
4. Such other functions, as may be entrusted to it by the Board of Directors, from time to time.
Name of Member | Designation |
---|---|
Mr. Gourav Munjal | Chairman |
Mr. Ameya Agnihotri | Member |
The terms of reference of the Finance Committee, inter alia, includes the following:
1. To borrow funds for and on behalf of your Company up to the maximum amount as determined by the Board of Directors of your Company from time to time;
2. To invest funds of your Company from time to time in equity shares, preference shares, debt securities, bonds, whether listed or unlisted, secured or unsecured, fixed deposits, units of mutual fund, security receipts, securities, etc. taking into consideration all investment parameters up to the maximum amount as determined by the Board of Directors of your Company from time to time and also to enter into any agreements including but not limited to enter into Share Purchase Agreement, Share Subscription Agreement, Shareholders Agreements, etc. as may be required to give effect to such transaction;
3. To allot securities of your Company including equity shares, preference shares, debt securities, bonds, etc. from time to time;
4. To borrow funds for meeting the short-term requirements of funds of your Company by issuing Commercial Paper including redemption and buyback of Commercial Paper and also to list the same as per the SEBI Regulations;
5. To avail intraday facilities from Banks/Financial Institution upto ₹ 3,000 Crores (Rupees Three Thousand Crore);
6. To offer assurances on behalf of Subsidiaries, in the form of guarantee, security, undertakings, letters (including without limitation, letter of comfort), deeds, declarations or any other instruments in connection with loan availed by them from Bank, Financial Institution, Non-Banking Financial Companies, other body corporates, etc. up to such limit, if applicable, as delegated/decided by the Board from time to time.
7. Powers relating to issuance and allotment of Debentures:
i. To determine terms and conditions and number of debentures to be issued;
ii. Determining timing, nature, type, pricing and such other terms and conditions of the issue including coupon rate, minimum subscription, retention of over-subscription, if any and early redemption thereof;
iii. To approve and make changes to the Draft Prospectus, to approve the Final Prospectus, including any corrigendum, amendments supplements thereto and the issue thereof;
iv. To approve all other matters relating to the issue and do all such acts, deeds, matters and things including execution of all such deeds, documents, instruments, applications and writings as it may, at its discretion, deem necessary and desirable for such purpose including without limitation the utilization of the issue proceeds, modify or alter any of the terms and conditions, including size of the Issue, as it may deem expedient, extension of issue and/or early closure of the issue;
8. Other Routine Matters.
Name of Member | Designation |
---|---|
Ms. Nirali Sanghi | Chairperson |
Mr. Gourav Munjal | Member |
Ms. Namita Godbole | Member |
Mr. Ameya Agnihotri | Member |
The terms of reference of the Environmental, Social and Governance (ESG) Committee, inter alia, includes the following:
1. Ensure that your company has an ESG Strategy and that it remains fit for purpose;
2. Ensure that objectives for ESG activities are in place and that key metrics are monitored and reported on;
3. Ensure compliance with relevant legal and regulatory requirements and industry standards and guidelines applicable to ESG matters;
4. Ensure that ESG related policies are in place, are regularly reviewed for their relevance, effectiveness, and compliance with relevant national and international regulations and are updated as necessary;
5. Monitor and review current and emerging ESG trends, relevant international standards, and legislative requirements; identify how these are likely to impact on the strategy, operations and reputation of your Company; and determine whether and how these are incorporated into or reflected in your Company’s ESG policies and objectives;
6. Approve any projects developed in response to the ESG strategy;
7. Identify, manage and mitigate or eliminate ESG risks in connection with your Company’s operations and corporate activity;
8. Approve all internal and external ESG reporting including information to be included in the annual report;
9. Review the results of any reviews or independent audits of your Company’s performance in regard to ESG matters and review any strategies and action plans developed by management in response to issues raised;
10. Make recommendations to the Board on any of the matters listed above that the Committee considers appropriate.
Name of Member | Designation |
---|---|
Mr. Ravindra Garikipati | Chairman |
Ms. Nirali Sanghi | Member |
Dr. Archana Hingorani | Member |
Mr. Milin Mehta | Member |
The terms of reference of the Independent Directors Committee, inter alia, includes the following:
1. To review the performance of Non-Independent Directors, the Chairman, and the Board as a whole and bring an objective view in the evaluation of Board and the management;
2. To assess the Quality, Quantity, and Timeliness of flow of Information between your Company’s Management and the Board that is necessary for the Board to effectively and reasonably perform their duties;
3. To deliberate on improving corporate credibility and governance standards and help in managing risks;
4. To bring an independent judgment to bear on the Board’s deliberations, especially on issues of strategy, performance, risk management, resources, key appointments, and standards of conduct;
5. Any other matter as may be deemed fit by the Independent Directors.
Name of Member | Designation |
---|---|
Mr. Ravindra Garikipati | Chairman |
Mr. Milin Mehta | Member |
Mr. Ameya Agnihotri | Member |
Mr. Yogesh Maroli | Member |
The terms of reference of the Information Technology (IT) Committee, inter alia, includes the following:
1. Ensure that the organization has put an effective IT strategic planning process in place.
2. Guide in preparation of IT Strategy, containing the overall strategy of the organization vis-à-vis adoption of IT and ensure that the IT Strategy aligns with the overall strategy of the organization towards the accomplishment of its business objectives.
3. Ensure that the IT Governance and Information Security Governance structure fosters accountability, effectiveness & efficiency with well-defined objectives and unambiguous responsibilities for each level in the organization.
4. Ensure putting in place processes for assessing and managing IT risks, including cyber security risks.
5. Ensure that the budgetary allocations for the IT function (including for IT security) are commensurate with the organization’s IT maturity, digital depth, threat environment and industry standards and are utilised in a manner intended for meeting the stated objectives.
6. Oversight over the Business Continuity Planning and Disaster Recovery Management of the organization.
Name of Member | Designation |
---|---|
Mr. Ravindra Garikipati | Chairman |
Mr. Milin Mehta | Member |
Mr. Ameya Agnihotri | Member |
Mr. Yogesh Maroli | Member |
The terms of reference of the Cyber Security Committee, inter alia, includes the following:
1. Facilitating development of information security policies, implementation of information security policies, standards and procedures to ensure that all identified information security risks are managed within the organization’s risk appetite.
2. Approving and monitoring major information security projects and the status of information security plans and budgets, establishing priorities, approving standards and procedures.
3. Supporting the development and implementation of an information security management programme.
4. Reviewing information/cyber security incidents, various information security assessments, monitoring and mitigation activities across the organization.
5. Reviewing security awareness programmes.
6. Assessing new developments or issues relating to cyber/information security.
7. Reporting to the Board/Board level Committee on information security activities.
Resignation of Chief Risk Officer of the Company
Appointment of Chief Risk Officer and Reconstitution of Risk Management Committee
Re-constitution of Risk Management Committee - 12.11.2024
Exercise of ESOP - 08.11.2024
Adjudication Order passed by SEBI - 04/11/2024
Transcript of Earnings Conference Call dated October 18, 2024
Shareholding Pattern for Quarter ended September 2024
Audio recording of Earnings Conference Call dated October 18, 2024
Reconciliation of Share Capital for the Quarter ended September 30, 2024
Newspaper Advertisements of Financial Results for the quarter and half year ended September, 2024
Report on Related Party Transactions for the quarter and half-year ended September 2024
Outcome of Board Meeting held on October 17, 2024
Intimation of Earnings Conference Call to be held on October 18, 2024
Earnings Conference Call to be held on October 18, 2024
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2024
Intimation of Board Meeting dated October 17, 2024
Intimation of trading window closure for the quarter and half year ended September 2024
Exercise of ESOP - 25.09.2024
Newspaper Advertisement after dispatch of Annual Report for the FY 2023-24
Newspaper Advertisement before dispatch of Annual Report for the FY 2023-24
Exercise of ESOP - 08.08.2024
Announcement under Regulation 30 of LODR - 02.08.2024
Transcript of Earnings Conference Call dated July 16, 2024
Shareholding Pattern for Quarter ended June 2024
Reconciliation of Share Capital for the Quarter ended June 30, 2024
Audio recording of Earnings Conference Call dated July 16, 2024
Newspaper Advertisements of Financial Results for the quarter ended June, 2024
Exercise of ESOP - 12.07.2024
Announcement under Regulation 30 of LODR-12.07.2024
Outcome of Board Meeting held on July 12, 2024
Intimation of Earnings Conference Call to be held on July 16, 2024
Disclosure under Regulation 30 of SEBI LODR-06.07.2024
Earnings Conference Call to be held on July 16, 2024
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2024
Intimation of Board Meeting dated July 12, 2024
Disclosure under Regulation 30 of SEBI LODR-02.07.2024
Intimation of trading window closure for the quarter ended June 2024
Exercise of ESOP - 20.06.2024
Exercise of ESOP - 04.06.2024
Disclosure under Reg 30 of SEBI LODR - Resignation of Mr. Narayan Gangadhar, MD & CEO
Exercise of ESOP - 21.05.2024
Exercise of ESOP - 24.04.2024
Outcome of Board Meeting held on April 24, 2024
Intimation of Earnings Conference Call to be held on April 25, 2024
Earnings Conference Call to be held on April 25, 2024
Intimation of Board Meeting dated April 24, 2024
Postal ballot 2017
Postal Ballot Form
Update on Postal Ballot
Postal Ballot E-Voting Advertisement English
Postal Ballot E-Voting Advertisement Marathi
Postal Ballot Results
Scrutinizer Report
Postal Ballot Results as per SEBI
Postal Ballot Notice
Postal ballot 2020
Postal Ballot Notice
Result of Postal Ballot
Scrutinizer Report
Newspaper Publication of Postal Ballot Notice - Business Standard
Postal Ballot Notice - Exchange Information
Postal Ballot Notice 2020
Postal ballot 2021
Newspaper publication of Postal Ballot Notice
Scrutinizer Report
Result of Postal Ballot
Addendum to Postal Ballot Notice
Postal Ballot Exchange intimation
Postal Ballot 2021
Postal ballot 2022
Result of Postal Ballot
Scrutinizer Report
Newspaper Publication of postal ballot intimation
Postal Ballot Notice intimation
Postal ballot 2023
Scrutinzer Report - November 2023
Result of Postal Ballot - November 2023
Newspaper advertisement of Postal Ballot Notice - November 2023
Intimation of Postal Ballot Notice - November 2023
Postal Ballot Notice - November 2023
Result of Postal Ballot-2023
Exchange Intimation - Postal Ballot notice
Postal Ballot Notice
Newspaper Publication of Postal Ballot Notice.
Familiarization of Independent Directors
Code of Conduct
Corporate Social Responsibility Policy
Dividend Distribution Policy
Nomination and Remuneration Policy
Policy for determination of Materiality of Information or Events
Terms of appointment of Independent Director
Authorised Key Managerial Personnel to determine materiality of events
Code of Practices and Procedures for Fair Disclosure
Whistle Blower Policy
Related Party Transaction Policy
Policy on preservation of Documents / Archival Policy
Policy on determining material subsidiaries
Board Diversity Policy
Investors Contacts
Link Intime India Private Limited
Address
Unit: 5paisa Capital Limited, C 101, 247 Park, L.B.S. Marg, Vikhroli (West) Mumbai, Maharashtra - 400083
Contact
+91-22-49186000 rnt.helpdesk@linkintime.co.in www.linkintime.co.inCorporate & Registered Office
Address
5paisa Capital Limited, IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23 Thane Industrial Area, Wagle Estate, Thane-400604
Contact
+91 89766 89766 support@5paisa.comMrs. Namita GodboleCompany Secretary & Chief Compliance officer
Address
Unit: 5paisa Capital Limited, C 101, 247 Park, L.B.S. Marg, Vikhroli (West) Mumbai, Maharashtra - 400083
Contact
+91-22-2580 6654 +91-22-4103 5000 csteam@5paisa.comFor Feedback & Grievances
Relating to dividend, dematerialisation - rematerialisation, transfer, Transmission of equity shares.
Contact
csteam@5paisa.comCorporate & Registered Office
Related to financial statements and
investor relations.